Company / Cost of Revenue
MEDIFAST INC Cost of Revenue History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$110.6M
FY2025
5-year range
$73.8M / $296.2M
FY2021-FY2025
Trend
-29.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 10 years, ranging from $69M in FY2018 to $296M in FY2023.
Based on SEC 10-K filings.
$111M in FY2025 with a 10-year CAGR of +2.9%.
Improved from $296M to $111M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- +2.9%
Key checks
Key Insights
- 5-year CAGR of -1.8%, indicating a declining trend.
- In FY2025, cost of revenue decreased 29.9% year-over-year.
- Peak cost of revenue was recorded in FY2023.
- Lowest cost of revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $110.6M | -29.9% |
| FY2024 | $157.8M | -46.7% |
| FY2023 | $296.2M | +144.6% |
| FY2020 | $121.1M | +64.2% |
| FY2019 | $73.8M | +7.1% |
| FY2018 | $68.9M | -3.6% |
| FY2017 | $71.5M | -6.1% |
| FY2016 | $76.1M | -8.9% |
| FY2015 | $83.5M | +1.0% |
| FY2014 | $82.7M | +12.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026